Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Pediatrics
Published in: European Journal of Pediatrics 3/2005

01-03-2005 | Correspondence

Somatostatin treatment of spontaneous chylothorax in an extremely low birth weight infant

Authors: Ryszard Lauterbach, Bozena Sczaniecka, Justyna Koziol, Marta Knapczyk

Published in: European Journal of Pediatrics | Issue 3/2005

Login to get access

Excerpt

Sir: Chylothorax in a premature infant is a relatively rare complication; however, the disease may cause significant breathing difficulty and may even necessitate the use of ventilatory support [2]. Patients may suffer from massive lymph drainage causing significant losses of fluid, protein and lymphocytes. We report a case of chylothorax which occurred suddenly on the 98th day after birth and was treated successfully with continuous intravenous infusion of octreotide. …
Literature
1.
Demos N, Kozel J, Scerbo J (2001) Somatostatin in the treatment of chylothorax. Chest 119: 964–966CrossRef
2.
Goto M, Kawamata K, Kitano M, Watanabe K, Chiba Y (2003) Treatment of chylothorax in a premature infant using somatostatin. J Perinatol 23: 563–564CrossRef
3.
Kelly R, Shumway S (2000) Conservative management of postoperative chylothorax using somatostatin. Ann Thorac Surg 69: 1944–1945CrossRefPubMed
4.
Mohseni-Bod H, Macrae D, Slavik Z (2004) Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe? Pediatr Crit Care Med 5: 356–357CrossRef
5.
Rosti L, Bini RM, Chessa M, Butera G, Drago M, Carminati M. (2002) The effectiveness of octreotide in the treatment of post-operative chylothorax. Eur J Pediatr 161: 149–150CrossRefPubMed
6.
Sivasli E, Dogru D, Aslan AT, Yurdakok M, Tekinalp G (2004) Spontaneous neonatal chylothorax treated with octreotide in Turkey: a case report. J Perinatol 24: 261–262CrossRef
Metadata
Title
Somatostatin treatment of spontaneous chylothorax in an extremely low birth weight infant
Authors
Ryszard Lauterbach
Bozena Sczaniecka
Justyna Koziol
Marta Knapczyk
Publication date
01-03-2005
Publisher
Springer-Verlag
Published in
European Journal of Pediatrics / Issue 3/2005
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-004-1608-5

Other articles of this Issue 3/2005

European Journal of Pediatrics 3/2005 Go to the issue

Short Report

Autoimmune haemolytic anaemia and renal Fanconi syndrome caused by valproate therapy

Short Report

Slipped capital femoral epiphysis during the treatment of precocious puberty with a gonadotropin-releasing hormone-agonist: aetiological considerations

Original Paper

Fomepizole as a therapeutic strategy in paediatric methanol poisoning. A case report and review of the literature

Short Report

A case of hyperinsulinism/hyperammonaemia syndrome: usefulness of the oral protein tolerance for the evaluation of treatment

Editorial Comment

Early recognition of basal cell naevus syndrome

Short Report

Extensive primary cutaneous herpes simplex virus type 1 infection in an infant following acute rotavirus gastroenteritis